Tejara Capital Ltd Invests $979,000 in Teleflex Incorporated $TFX

Tejara Capital Ltd purchased a new stake in Teleflex Incorporated (NYSE:TFX) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 8,000 shares of the medical technology company’s stock, valued at approximately $979,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. boosted its holdings in Teleflex by 23.6% during the 2nd quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company’s stock worth $9,870,000 after acquiring an additional 15,935 shares during the last quarter. Speece Thorson Capital Group Inc. lifted its position in shares of Teleflex by 2.4% during the second quarter. Speece Thorson Capital Group Inc. now owns 89,843 shares of the medical technology company’s stock valued at $10,634,000 after purchasing an additional 2,096 shares in the last quarter. Creative Planning boosted its holdings in Teleflex by 76.5% during the second quarter. Creative Planning now owns 10,338 shares of the medical technology company’s stock worth $1,224,000 after purchasing an additional 4,480 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Teleflex by 113.9% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 58,047 shares of the medical technology company’s stock worth $7,366,000 after purchasing an additional 30,912 shares in the last quarter. Finally, CWM LLC grew its position in Teleflex by 160.8% in the 2nd quarter. CWM LLC now owns 11,904 shares of the medical technology company’s stock worth $1,409,000 after purchasing an additional 7,340 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Price Performance

TFX opened at $104.40 on Friday. The firm has a 50-day moving average price of $116.10 and a 200-day moving average price of $119.60. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $184.34. The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $4.61 billion, a price-to-earnings ratio of -14.20, a PEG ratio of 1.38 and a beta of 0.93.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, topping the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The company had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. During the same period last year, the firm earned $3.49 EPS. Teleflex’s revenue for the quarter was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were given a dividend of $0.34 per share. The ex-dividend date was Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.3%. Teleflex’s dividend payout ratio is currently -18.50%.

Analyst Ratings Changes

Several research firms have commented on TFX. Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 target price on shares of Teleflex in a research report on Wednesday, December 17th. Needham & Company LLC upgraded Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price target on the stock in a report on Tuesday. Wall Street Zen cut Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Truist Financial raised their target price on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Finally, Wells Fargo & Company lowered their target price on Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research note on Thursday. Two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $139.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.